triple-hormone-receptor agonist retatrutide for obesity PDF) Triple hormone receptor metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Triple hormone receptor agonist retatrutide

Protein helps support lean muscle mass and keeps you feeling full longer

The TRIUMPH-4 readout of ~28.7% places retatrutide on track to become the most effective GLP-class weight-loss drug yet if the remaining trials replicate the result and the safety profile holds

Among the 58% of adults who say they want to lose weight, nearly one-third (32%) expect to start a prescription GLP-1 drug in 2026, which translates to an estimated 48 million American adults including 9% who say they definitely will and 23% who say they probably will

Studies also noted better lipid profiles , improved liver enzymes , and lower inflammatory markers , suggesting broad metabolic activity

Retatrutide targets three receptors, which may translate into broader metabolic support for every dollar spent, depending on individual response

Research labs use it to study multi-hormonal metabolic signaling, energy homeostasis, and the interactions between overlapping incretin pathways